Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 1
2009 1
2012 2
2013 3
2014 6
2015 3
2016 3
2021 10
2022 12
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma.
Carloni R, Sabbioni S, Rizzo A, Ricci AD, Palloni A, Petrarota C, Cusmai A, Tavolari S, Gadaleta-Caldarola G, Brandi G. Carloni R, et al. Among authors: gadaleta caldarola g. J Hepatocell Carcinoma. 2023 Sep 6;10:1445-1463. doi: 10.2147/JHC.S390963. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37701562 Free PMC article. Review.
Chronic Inflammation in Obesity and Cancer Cachexia.
Divella R, Gadaleta Caldarola G, Mazzocca A. Divella R, et al. Among authors: gadaleta caldarola g. J Clin Med. 2022 Apr 14;11(8):2191. doi: 10.3390/jcm11082191. J Clin Med. 2022. PMID: 35456284 Free PMC article. Review.
Toward personalized therapy for cholangiocarcinoma: new insights and challenges.
Rizzo A, Ricci AD, Gadaleta-Caldarola G, Brandi G. Rizzo A, et al. Among authors: gadaleta caldarola g. Expert Rev Gastroenterol Hepatol. 2021 Nov;15(11):1241-1243. doi: 10.1080/17474124.2021.1984879. Epub 2021 Oct 11. Expert Rev Gastroenterol Hepatol. 2021. PMID: 34553646 No abstract available.
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand?
Carloni R, Rizzo A, Ricci AD, Frega G, Federico AD, Palloni A, Marco MD, Gadaleta-Caldarola G, Brandi G. Carloni R, et al. Among authors: gadaleta caldarola g. Future Oncol. 2022 Mar;18(8):1023-1034. doi: 10.2217/fon-2021-0905. Epub 2022 Feb 3. Future Oncol. 2022. PMID: 35109664 Review.
Sorafenib: 10 years after the first pivotal trial.
Gadaleta-Caldarola G, Infusino S, Divella R, Ferraro E, Mazzocca A, De Rose F, Filippelli G, Abbate I, Brandi M. Gadaleta-Caldarola G, et al. Future Oncol. 2015;11(13):1863-80. doi: 10.2217/fon.15.85. Future Oncol. 2015. PMID: 26161924 Review.
41 results